Back
ANGO
HealthcareAngioDynamics, Inc.
Next Earnings: Q2 2026
Tuesday, January 6, 2026
Loading...
ANGO EPS History & Predictions
Actual
Consensus
Wall Street
$-0.10consensus
GPT-5.2
$-0.21▼
Claude-opus
$-0.07▲
Gemini 3 Pro
$-0.01▲
Grok-4
$-0.02▲
Q2 2026 Predictions
AI analyst forecasts for the upcoming earnings release. Click a model to see its reasoning.
GPT-5.2
openrouterEPS
$-0.21
Revenue
$0.08B
Conf.
46%Click for details →
Claude-opus
openrouterEPS
$-0.07
Revenue
$0.08B
Conf.
72%Click for details →
Gemini 3 Pro
openrouterEPS
$-0.01
Revenue
$0.08B
Conf.
85%Click for details →
Grok-4
openrouterEPS
$-0.02
Revenue
$0.08B
Conf.
85%Click for details →
Predictions Comparison
AI model predictions compared to Wall Street consensus
| Model | EPS Estimate | Revenue Estimate | vs Consensus | Confidence | |
|---|---|---|---|---|---|
GPT-5.2openrouter | $-0.21 | $0.08B | +110.0% | 46% | |
Claude-opusopenrouter | $-0.07 | $0.08B | -30.0% | 72% | |
Gemini 3 Proopenrouter | $-0.01 | $0.08B | -90.0% | 85% | |
Grok-4openrouter | $-0.02 | $0.08B | -80.0% | 85% | |
| Wall Street Consensus | $-0.10 | $0.08B | — | — |
Wall Street Consensus
Compare AI predictions against Wall Street analyst consensus
Consensus EPS
$-0.14
Last Reported EPS
$-0.26
Last Surprise
-85.71%
Report Date
10/2/2025
Quarterly Earnings Surprise Amount
Historical performance vs Wall Street consensus
| Fiscal Quarter End | Date Reported | Earnings Per Share* | Consensus EPS* Forecast | % Surprise |
|---|---|---|---|---|
| Q1 2026 | 10/2/2025 | -0.26 | — | -85.71 |
| Q4 2025 | 7/18/2025 | -0.15 | — | -15.38 |
| Q3 2025 | 4/2/2025 | -0.11 | — | 15.38 |
| Q2 2025 | 1/8/2025 | -0.26 | — | -136.36 |
* EPS values are adjusted for stock splits
Financial Statements
Historical data with AI projections for Q2 2026
All values in Millions (USD) unless otherwise noted
AI Projections | ||||||||
|---|---|---|---|---|---|---|---|---|
| Line Item | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | GPT-5.2Q2 2026 | Claude-opusQ2 2026 | Gemini 3 ProQ2 2026 | Grok-4Q2 2026 |
| Revenue | ||||||||
| Revenue | 72.84 | 72.00 | 80.16 | 75.71 | 76.20+0.6% | 77.50+2.4% | 78.50+3.7% | 83.00+9.6% |
| Cost Of Revenue | 32.94 | 33.15 | 37.94 | 33.85 | 34.20+1.0% | 34.50+1.9% | 34.90+3.1% | 37.35+10.3% |
| Cost & Gross Profit | ||||||||
| Gross Profit | 39.91 | 38.86 | 42.22 | 41.86 | 42.00+0.3% | 43.00+2.7% | 43.60+4.2% | 45.65+9.1% |
| Cost And Expenses | 83.94 | 81.98 | 85.95 | 86.37 | 84.70-1.9% | 83.00-3.9% | 85.40-1.1% | 85.85-0.6% |
| Operating Expenses | ||||||||
| Research And Development Expenses | 6.43 | 6.91 | 6.59 | 6.42 | 6.50+1.3% | 6.50+1.3% | 6.50+1.3% | 6.50+1.3% |
| General And Administrative Expenses | 10.39 | 10.49 | 10.24 | 12.55 | 11.50-8.4% | 10.50-16.4% | 12.00-4.4% | 12.00-4.4% |
| Selling And Marketing Expenses | 25.59 | 25.50 | 26.44 | 28.13 | 26.00-7.6% | 26.50-5.8% | 26.50-5.8% | 26.00-7.6% |
| Selling General And Administrative Expenses | 35.98 | 35.99 | 36.67 | 40.69 | 37.50-7.8% | 37.00-9.1% | 38.50-5.4% | 38.00-6.6% |
| Other Expenses | 8.59 | 5.92 | 4.74 | 5.41 | 5.10-5.7% | 5.00-7.6% | 5.50+1.6% | 4.50-16.8% |
| Operating Expenses | 51.00 | 48.83 | 48.01 | 52.51 | 50.50-3.8% | 48.50-7.6% | 50.50-3.8% | 48.50-7.6% |
| Interest Expense | 0 | 0 | 0 | 0.004 | 0.005+25.0% | 0.005+25.0% | 0.005+25.0% | 0.005+25.0% |
| Total Other Income Expenses Net | 0.246 | 5.57 | -0.322 | -0.182 | -0.250-37.4% | 0+100.0% | -0.200-9.9% | -0.145+20.3% |
| Income Tax Expense | -0.110 | -0.002 | -0.060 | 0.065 | 0-100.0% | 0.050-23.1% | 0.050-23.1% | 0.050-23.1% |
| Other Income/Expense | ||||||||
| Net Interest Income | 0.234 | 0.135 | 0.003 | -0.004 | 0.045 | 0.045 | 0.145 | 0.045 |
| Interest Income | 0.234 | 0.135 | 0.003 | 0 | 0.050 | 0.050 | 0.150 | 0.050 |
| Non Operating Income Excluding Interest | -6.02 | -3.33 | -2.15 | 0.178 | -0.295-265.7% | 0-100.0% | -0.200-212.4% | -0.200-212.4% |
| Other Adjustments To Net Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income & EPS | ||||||||
| Operating Income | -11.09 | -9.97 | -5.79 | -10.66 | -8.50+20.2% | -5.50+48.4% | -6.90+35.2% | -2.85+73.3% |
| Income Before Tax | -10.85 | -4.41 | -6.11 | -10.84 | -8.75+19.3% | -5.50+49.3% | -7.10+34.5% | -2.90+73.2% |
| Net Income From Continuing Operations | -10.74 | -4.41 | -6.05 | -10.90 | -8.75+19.7% | -5.55+49.1% | -7.15+34.4% | -2.95+72.9% |
| Net Income From Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | -10.74 | -4.41 | -6.05 | -10.90 | -8.75+19.7% | -5.55+49.1% | -7.15+34.4% | -2.95+72.9% |
| Net Income Deductions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bottom Line Net Income | -10.74 | -4.41 | -6.05 | -10.90 | -8.75+19.7% | -5.55+49.1% | -7.15+34.4% | -2.95+72.9% |
| Eps | -$0.2600 | -$0.1100 | -$0.1500 | -$0.2600 | -$0.2100+19.2% | -$0.1300+50.0% | -$0.1700+34.6% | -$0.0700+73.1% |
| Eps Diluted | -0.26 | -0.11 | -0.15 | -0.26 | -0.21+19.2% | -0.13+50.0% | -0.17+34.6% | -0.07+73.1% |
| Other | ||||||||
| Filing Date | 0.002 | 0.002 | 0.002 | 0.002 | — | — | — | — |
| Fiscal Year | 0.002 | 0.002 | 0.002 | 0.002 | — | — | — | — |
| Depreciation And Amortization | 6.86 | 6.32 | 5.83 | 6.02 | 6.00-0.3% | 5.50-8.6% | 6.00-0.3% | 6.00-0.3% |
| Ebitda | 1.79 | -0.329 | 2.20 | -4.81 | -2.75+42.9% | -0.050+99.0% | -0.955+80.2% | 3.15+165.4% |
| Ebit | -5.07 | -6.65 | -3.63 | -10.83 | -8.75+19.2% | -5.55+48.8% | -6.96+35.8% | -2.85+73.7% |
| Weighted Average Shs Out | 40,922,000 | 40,853,000 | 40,984,000 | 41,174,000 | 41,300,000+0.3% | 41,400,000+0.5% | 41,300,000+0.3% | 41,300,000+0.3% |
| Weighted Average Shs Out Dil | 40,922,000 | 40,853,000 | 40,984,000 | 41,174,000 | 41,300,000+0.3% | 41,400,000+0.5% | 41,300,000+0.3% | 41,300,000+0.3% |